Melbourne scientists launch gene therapy to halt childhood blindness in Usher syndrome
Melbourne scientists are developing EDITRA, a gene therapy to treat Usher syndrome, which causes progressive blindness in children like five-year-old Poppy Stevens. Researchers at the Centre for Eye Research Australia created the treatment through spin-out company Adara Bio, correcting genetic spelling mistakes via RNA instead of replacing large genes.
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 16 Oct 2026, 08:30 UTC · Updated 16 Oct 2026, 08:40 UTC
Summary by OZbrief Editorial. Original report: SMH. Editorial policy · Corrections
Trending
- CFMEU delegate charged with drug trafficking after weapons trade at union HQ
- Eighteen-year-old P-plater faces 17 charges after crashing into Newcastle Knights fans
- Albanese reverses tax office credit card ban, undermining treasurer Chalmers
- Single Powerball ticket claims entire $100 million jackpot in historic draw
- Jack Viney ends 14-year Melbourne career, joins West Coast as captain
- UK households pay £13,961 extra on bills since 2021, TUC warns